Added to YB: 2025-02-07
Pitch date: 2025-02-07
EVO [bullish]
Evotec SE
-56.29%
current return
Author Info
No bio for this author
Company Info
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
Market Cap
EUR 612.5M
Pitch Price
EUR 4.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
-11.42
P/E
-3.10
EV/Sales
0.87
Sector
Life Sciences Tools and Services
Category
growth
Evotec SE: A Pioneering AI-Driven CDMO with Takeover Potential
EVO/EVT: Vertically integrated CDMO spanning drug discovery to biologics manufacturing. Positioned for AI-powered drug discovery with PanOmics/PanHunter. 140 co-owned drug pipeline, biologics mfg +75% YoY. New leadership driving efficiency. Trades 2x rev. Takeover potential (rejected €12/share offer). Biotech cycle near bottom.
Read full article (1 min)